Generated Narrative: ConceptMap ch-vacd-immunoglobulin-targetdiseases-cm Mapping from CH VACD Swissmedic Authorized Immunoglobulin Codes to CH VACD Target disease and illnesses undergone for immunization Group 1 Mapping from CH VACD Swissmedic Authorized Immunoglobulin Codes to SNOMED CT (all versions) Source Concept Details Relationship Target Concept Details Codes from CH VACD Swissmedic Authorized Immunoglobulin Codes Codes from SNOMED CT (all versions) 00687-01 Berirab 2 ml, Injektionslösung is related to 14168008 Rabies (disorder) 00687-02 Berirab 5 ml, Injektionslösung is related to 14168008 Rabies (disorder) 69039-02 Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie is related to 55735004 Respiratory syncytial virus infection (disorder) 69039-01 Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie is related to 55735004 Respiratory syncytial virus infection (disorder) 68222-01 Cutaquig 165 mg/ml, Injektionslösung is related to 58606001 Primary immune deficiency disorder (disorder) is related to 33286000 Secondary immune deficiency disorder (disorder) 65992-01 Cuvitru 200 mg/ml, Injektionslösung is related to 58606001 Primary immune deficiency disorder (disorder) is related to 33286000 Secondary immune deficiency disorder (disorder) 00506-02 Cytotect CP Biotest, Infusionslösung is related to 28944009 Infection caused by Cytomegalovirus (disorder) 00701-02 Gammanorm, Injektionslösung is related to 58606001 Primary immune deficiency disorder (disorder) is related to 16318001000119107 Hypogammaglobulinemia due to multiple myeloma (disorder) 00668-01 Gamunex 10%, solution pour injection intraveineuse is related to 14189004 Measles (disorder) 00488-02 Hepatect CP, Infusionslösung is related to 66071002 Viral hepatitis type B (disorder) 00674-01 Hepatitis-B-Immunglobulin Behring, Injektionslösung is related to 66071002 Viral hepatitis type B (disorder) 66410-01 Hizentra 200mg/ml, Injektionslösung zur s.c. Anwendung, Fertigspritze is related to 58606001 Primary immune deficiency disorder (disorder) is related to 33286000 Secondary immune deficiency disorder (disorder) 61547-01 Hizentra, Injektionslösung zur s.c. Anwendung is related to 58606001 Primary immune deficiency disorder (disorder) is related to 33286000 Secondary immune deficiency disorder (disorder) 66684-01 HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung is related to 58606001 Primary immune deficiency disorder (disorder) is related to 33286000 Secondary immune deficiency disorder (disorder) 58157-01 Ig Vena Kedrion 50 g/I, solution pour infusion is related to 58606001 Primary immune deficiency disorder (disorder) is related to 33286000 Secondary immune deficiency disorder (disorder) 62913-01 Intratect 10%, Infusionslösung is related to 58606001 Primary immune deficiency disorder (disorder) is related to 33286000 Secondary immune deficiency disorder (disorder) 57676-01 Intratect 5%, Infusionslösung is related to 58606001 Primary immune deficiency disorder (disorder) is related to 33286000 Secondary immune deficiency disorder (disorder) 66332-03 Iqymune 10g/100ml, Infusionslösung is related to 58606001 Primary immune deficiency disorder (disorder) is related to 33286000 Secondary immune deficiency disorder (disorder) 66332-04 Iqymune 20g/200ml, Infusionslösung is related to 58606001 Primary immune deficiency disorder (disorder) is related to 33286000 Secondary immune deficiency disorder (disorder) 66332-01 Iqymune 2g/20ml, Infusionslösung is related to 58606001 Primary immune deficiency disorder (disorder) is related to 33286000 Secondary immune deficiency disorder (disorder) 66332-02 Iqymune 5g/50ml, Infusionslösung is related to 58606001 Primary immune deficiency disorder (disorder) is related to 33286000 Secondary immune deficiency disorder (disorder) 57469-01 Kiovig, Infusionslösung is related to 58606001 Primary immune deficiency disorder (disorder) is related to 33286000 Secondary immune deficiency disorder (disorder) 60323-01 Octagam 10 %, Lösung zur intravenösen Anwendung is related to 58606001 Primary immune deficiency disorder (disorder) is related to 33286000 Secondary immune deficiency disorder (disorder) 58314-01 Privigen, Infusionslösung is related to 58606001 Primary immune deficiency disorder (disorder) is related to 33286000 Secondary immune deficiency disorder (disorder) 53609-02 Rhophylac 300, Injektionslösung is related to 165746003 RhD negative (finding) 65695-02 Synagis 100 mg/1 ml, Injektionslösung is related to 55735004 Respiratory syncytial virus infection (disorder) 65695-01 Synagis 50 mg/0.5 ml, Injektionslösung is related to 55735004 Respiratory syncytial virus infection (disorder) 00673-02 Tetagam P, Injektionslösung is related to 76902006 Tetanus (disorder) 59374-01 Uman Big 180 UI/1 ml, solution pour injection intramusculaire is related to 66071002 Viral hepatitis type B (disorder) 59374-02 Uman Big 540 UI/3 ml, solution pour injection intramusculaire is related to 66071002 Viral hepatitis type B (disorder) 59451-01 Varitect CP, Lösung zur intravenösen Injektion is related to 38907003 Varicella (disorder) 59373-02 Venbig 2500 U.I/50 ml, poudre et solution pour injection intraveineuse is related to 66071002 Viral hepatitis type B (disorder) 59373-01 Venbig 500 U.I/10 ml, poudre et solution pour injection intraveineuse is related to 66071002 Viral hepatitis type B (disorder) 68471-01 Xevudy, Konzentrat zur Herstellung einer Infusionslösung is related to 840539006 Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) 66344-01 Zinplava, Konzentrat zur Herstellung einer Infusionslösung is related to 56688005 Clostridial infection (disorder) 61639-01 Zutectra, Injektionslösung is related to 66071002 Viral hepatitis type B (disorder)
Mappings from ImmunGlobuline to TargetDisease according to the correcsponding valuesets
This artefact includes content from SNOMED Clinical Terms® (SNOMED CT®) which is copyright of the International Health Terminology Standards Development Organisation (IHTSDO). Implementers of these artefacts must have the appropriate SNOMED CT Affiliate license - for more information contact http://www.snomed.org/snomed-ct/getsnomed-ct or info@snomed.org.
Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie
Respiratory syncytial virus infection (disorder)
Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie
Primary immune deficiency disorder (disorder)
Secondary immune deficiency disorder (disorder)
Infection caused by Cytomegalovirus (disorder)
Hypogammaglobulinemia due to multiple myeloma (disorder)
Gamunex 10%, solution pour injection intraveineuse
Hepatitis-B-Immunglobulin Behring, Injektionslösung
Hizentra 200mg/ml, Injektionslösung zur s.c. Anwendung, Fertigspritze
Hizentra, Injektionslösung zur s.c. Anwendung
HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung
Ig Vena Kedrion 50 g/I, solution pour infusion
Octagam 10 %, Lösung zur intravenösen Anwendung
Uman Big 180 UI/1 ml, solution pour injection intramusculaire
Uman Big 540 UI/3 ml, solution pour injection intramusculaire
Varitect CP, Lösung zur intravenösen Injektion
Venbig 2500 U.I/50 ml, poudre et solution pour injection intraveineuse
Venbig 500 U.I/10 ml, poudre et solution pour injection intraveineuse
Xevudy, Konzentrat zur Herstellung einer Infusionslösung
Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Zinplava, Konzentrat zur Herstellung einer Infusionslösung